AUS
NZ
UK
CA
USA
IND
Highlights
FTSE 100 moves slightly lower ahead of Bank of England’s policy announcement
Sainsbury (LSE:SBRY) updates its annual outlook and confirms a special payout
AstraZeneca (LSE:AZN) posts stronger results, while ITV (LSE:ITV) notes advertising slowdown
FTSE 100 trades slightly softer ahead of the Bank of England decision as Sainsbury upgrades guidance, ITV faces advertising pressure, and AstraZeneca posts solid quarterly results.
The Retail Stocks and Healthcare Stocks segments of the FTSE 100 moved modestly on Thursday as market participants awaited the Bank of England’s upcoming interest rate decision. The FTSE 350 Companies index also reflected mild weakness across broader UK equities, with sterling maintaining a subdued tone against major currencies. Trading sentiment remained cautious amid mixed economic readings and corporate earnings updates across various sectors.
Mixed Market Sentiment Across the London Session
The London Stock Exchange experienced a subdued tone through the session as most large-cap shares traded near flat levels. The FTSE benchmark remained slightly weaker through morning trade, reflecting a market environment attentive to upcoming fiscal announcements and global monetary signals. The economic backdrop was softened by data from the construction sector, which reflected a notable contraction, extending the subdued trend across infrastructure and housing activity.
Financial institutions within the Blue-Chip Stocks category displayed relatively stable movement, supported by reports that upcoming fiscal plans may not impose additional burdens on major lenders. The FTSE 350 Banks Index advanced modestly, cushioning some of the broader index weakness.
Across the trading floor, corporate updates shaped intraday performance for key Consumer Stocks, Healthcare Stocks, and Communication Stocks. Among the most closely watched names were J Sainsbury (LSE:SBRY), ITV (LSE:ITV), and AstraZeneca (LSE:AZN), each offering detailed updates that influenced market tone through the session.
Sainsbury Enhances Profit Outlook with Strong Retail Momentum
In the latest statement, Sainsbury confirmed stronger retail activity across grocery and general merchandise divisions, resulting in an upgraded forecast for its full-year retail underlying operating profit. The company also announced a one-off dividend distribution, reinforcing its focus on shareholder returns within its capital allocation strategy.
The retail group highlighted increased grocery volumes, improved customer perception regarding value, and further operational efficiencies as core drivers of this performance. Sainsbury also mentioned continued investment in its store network and digital expansion, aimed at maintaining steady market share in a competitive consumer environment.
In addition, the company reaffirmed plans to streamline operations through divestments linked to its financial services segment, providing additional flexibility for reinvestment in its primary retail operations. The update placed Sainsbury among the few FTSE constituents delivering upward revisions in annual performance guidance this quarter.
ITV Faces Headwinds in Advertising Despite Strength in Studios and Digital
ITV presented its trading statement showing resilience within its Studios and digital divisions, even as advertising performance softened in the final quarter of the year. The media group indicated that digital ad revenue and content production maintained double-digit growth, reflecting strong demand for proprietary programming and streaming initiatives.
However, the company noted a downturn in traditional television advertising revenue due to cautious marketing spending across sectors ahead of the forthcoming national budget. ITV outlined a temporary cost-saving programme designed to mitigate the revenue impact by adjusting production timelines and administrative expenses.
The broadcaster emphasised its ongoing transition toward digital and global content markets, highlighting continued engagement through ITVX, its online streaming platform. Despite the slowdown in advertising, the company reiterated confidence in its diversified media strategy, underscoring the enduring strength of its production portfolio.
AstraZeneca Delivers Strong Results with Robust Pharmaceutical Demand
AstraZeneca’s quarterly performance exceeded expectations in revenue and core earnings, supported by demand across oncology, cardiovascular, and respiratory treatments. The pharmaceutical company also referenced positive progress within its research and development pipeline, particularly within biologics and next-generation therapies.
The firm maintained its existing full-year guidance, reflecting a measured approach despite the revenue improvement. AstraZeneca’s management reaffirmed ongoing commitments to scientific advancement, sustainability objectives, and manufacturing innovation.
The update came as part of a broader wave of healthcare results across the FTSE 100, where large-cap pharmaceutical and medical equipment companies demonstrated steady operational execution. AstraZeneca’s ongoing development in immunotherapy and rare disease treatments continues to form a significant share of its research focus, underscoring the group’s standing among leading Healthcare Stocks in the index.
Other Corporate Updates Across the FTSE Landscape
Several other UK-listed corporations reported updates that shaped broader market sentiment. Smith & Nephew (LSE:SN) registered a decline in share value after reporting weaker within its US orthopaedics division, particularly in knee implants. The company maintained its full-year guidance but acknowledged operational challenges in specific markets.
Diageo (LSE:DGE) recorded stable organic net performance during its fiscal first quarter. Gains in European and African regions offset softness in Asia and the United States. The beverages company emphasised progress in its ongoing efficiency initiative known as “Accelerate,” aimed at optimising supply chains and maintaining steady cash flow.
Hikma Pharmaceuticals (LSE:HIK) reaffirmed its current-year guidance, while adjusting medium-term targets related to manufacturing and distribution schedules. The update reflected operational timing adjustments in its US-based facilities, with ongoing efforts to enhance product delivery reliability across geographies.
The London Stock Exchange Group also announced a new data partnership with Nasdaq, focusing on private-market analytics. The collaboration seeks to strengthen cross-border financial data infrastructure and enhance institutional access to private company information within both regions.
Broader Economic Context and Outlook for the UK Market
UK equity performance during the session was shaped by broader macroeconomic dynamics. The Bank of England’s rate decision remained central to the day’s agenda, with expectations centred on policy continuity. The sterling remained steady near multi-month lows, reflecting investor attention on inflation persistence and fiscal planning ahead of the upcoming budget announcement.
Construction and housing sectors displayed weaker readings through the October period, with civil engineering activity particularly subdued. This contributed to the ongoing narrative of decelerating output in non-service segments of the economy. However, moderate resilience was observed among Financial Stocks and certain defensive sectors, limiting the extent of the overall decline in market indices.
In the global context, the interplay between UK fiscal developments, global supply chain normalisation, and corporate earnings updates continued to guide sentiment across European trading sessions. The session reflected a balance between caution and optimism as investors navigated economic recalibration following years of volatility and adjustment.
